Plumbagin ameliorates LPS‐induced acute lung injury by regulating PI3K/AKT/mTOR and Keap1‐Nrf2/HO‐1 signalling pathways
Journal of Cellular and Molecular Medicine · 2024-07 · 28 (13)
DOI: 10.1111/jcmm.18386 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 11.07.2024. Verfasst von Zhengjia Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, China-Japan Union Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Acute Lung Injury, NF-E2-Related Factor 2, TOR Serine-Threonine Kinases, Kelch-Like ECH-Associated Protein 1. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Education Department of Jilin Province, Wu Jieping Medical Foundation, Education Department of Jilin Province.
Abstract (Originalsprache)
Acute lung injury (ALI) is a major pathophysiological problem characterized by severe inflammation, resulting in high morbidity and mortality. Plumbagin (PL), a major bioactive constituent extracted from the traditional Chinese herb Plumbago zeylanica , has been shown to possess anti‐inflammatory and antioxidant pharmacological activities. However, its protective effect on ALI has not been extensively studied. The objective of this study was to investigate the protective effect of PL against ALI induced by LPS and to elucidate its possible mechanisms both in vivo and in vitro. PL treatment significantly inhibited pathological injury, MPO activity, and the wet/dry ratio in lung tissues, and decreased the levels of inflammatory cells and inflammatory cytokines TNF‐α, IL‐1β, IL‐6 in BALF induced by LPS. In addition, PL inhibited the activation of the PI3K/AKT/mTOR signalling pathway, increased the activity of antioxidant enzymes CAT, SOD, GSH and activated the Keap1/Nrf2/HO‐1 signalling pathway during ALI induced by LPS. To further assess the association between the inhibitory effects of PL on ALI and the PI3K/AKT/mTOR and Keap1/Nrf2/HO‐1 signalling, we pretreated RAW264.7 cells with 740Y‐P and ML385. The results showed that the activation of PI3K/AKT/mTOR signalling reversed the protective effect of PL on inflammatory response induced by LPS. Moreover, the inhibitory effects of PL on the production of inflammatory cytokines induced by LPS also inhibited by downregulating Keap1/Nrf2/HO‐1 signalling. In conclusion, the results indicate that the PL ameliorate LPS‐induced ALI by regulating the PI3K/AKT/mTOR and Keap1‐Nrf2/HO‐1 signalling, which may provide a novel therapeutic perspective for PL in inhibiting ALI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, China-Japan Union Hospital of Jilin University, Changchun, China.
- Department of Respiratory, China-Japan Union Hospital of Jilin University, Changchun, China.
ORCID-Profile: Lei Xu
Förderung
- The Education Department of Jilin Province
- Wu Jieping Medical Foundation
- Education Department of Jilin Province
Zitieren
APA
Liu, Z., Wei, J., Sun, H., & Xu, L. (2024). Plumbagin ameliorates LPS‐induced acute lung injury by regulating PI3K/AKT/mTOR and Keap1‐Nrf2/HO‐1 signalling pathways. Journal of Cellular and Molecular Medicine, 28(13). https://doi.org/10.1111/jcmm.18386
Vancouver
Liu Z, Wei J, Sun H, Xu L. Plumbagin ameliorates LPS‐induced acute lung injury by regulating PI3K/AKT/mTOR and Keap1‐Nrf2/HO‐1 signalling pathways. Journal of Cellular and Molecular Medicine. 2024;28(13). doi:10.1111/jcmm.18386
BibTeX
@article{Liu2024,
author = {Liu, Zhengjia and Wei, Jiahui and Sun, Hongbin and Xu, Lei},
title = {Plumbagin ameliorates LPS‐induced acute lung injury by regulating PI3K/AKT/mTOR and Keap1‐Nrf2/HO‐1 signalling pathways},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
volume = {28},
number = {13},
doi = {10.1111/jcmm.18386}
}
EUVIMED